Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$22.43NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/16/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$18.21 (3)
Ask (Size)$23.60 (12)
Day Low / HighN/A - N/A
Volume1.0 K

Aimmune Therapeutics Submits EU Marketing Authorization Application for Peanut Allergy Drug

7:34AM ET 6/28/2019 MT Newswires
Aimmune Therapeutics (AIMT) said it has submitted a marketing authorization application to the European Medicines Agency for AR101, an investigational treatment for peanut allergy.

The drug is being evaluated as an oral treatment to reduce the frequency and severity of allergic reactions following exposure to peanuts in children and adolescents ages 4 to 17.

A biologics license application for the drug is under review by the US Food and Drug Administration and is expected to take until late January. The allergenic products advisory committee of the FDA will review the application at its Sept. 13 meeting.

Price: 19.92, Change: +0.30, Percent Change: +1.53